Results for tag: "Brucellosis Drug"

Brucellosis is an infectious disease caused by bacteria of the genus Brucella. It is a zoonotic disease, meaning it can be transmitted from animals to humans. Treatment of brucellosis typically involves antibiotics, such as doxycycline, rifampin, and streptomycin. The brucellosis drug market is a subset of the infectious diseases drug market, which is composed of drugs used to treat a variety of infectious diseases. The brucellosis drug market is expected to grow due to increasing prevalence of the disease, rising awareness of the disease, and increasing government initiatives to control the spread of the disease. Additionally, the development of new drugs and the availability of generic drugs are expected to drive the market. Some companies in the brucellosis drug market include Pfizer, Merck & Co., GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more